Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neighbourly Pharmacy Inc T.NBLY.R


Primary Symbol: T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Post by retiredcfon Jan 30, 2023 7:58am
194 Views
Post# 35253498

Assessment

Assessment

From its peak in 2022, NBLY is down 50%. Is this price action not telling you there is something terribly wrong with the company and time to cut bait and salvage what is left in the stock price?

Well, we could list a few hundred or more stocks down more than 50% from their 2022 peak. But not all would be sells. On NBLY, certainly the price action is not positive. We like to take cues from the market as best we can, but we also think time is needed as well. NBLY has only been public since May 2021 in hardly an ideal market backdrop. EPS is expected to more than double in FY2024 (March year end) and for now we are comfortable. (5iResearch)


<< Previous
Bullboard Posts
Next >>